Sign In
Buy VNNVF
VONOVIA SE Earnings Calls
| Release date | Nov 05, 2025 |
| EPS estimate | $0.563 |
| EPS actual | $3.20 |
| EPS Surprise | 468.38% |
| Revenue estimate | 855.223M |
| Revenue actual | 975.073M |
| Revenue Surprise | 14.01% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.476 |
| EPS actual | $0.447 |
| EPS Surprise | -6.03% |
| Revenue estimate | 850.151M |
| Revenue actual | 1.593B |
| Revenue Surprise | 87.35% |
| Release date | May 07, 2025 |
| EPS estimate | $0.519 |
| EPS actual | $0.658 |
| EPS Surprise | 26.78% |
| Revenue estimate | 842.981M |
| Revenue actual | 1.494B |
| Revenue Surprise | 77.24% |
| Release date | Dec 31, 2024 |
| EPS estimate | - |
| EPS actual | -$0.440 |
| Revenue estimate | - |
| Revenue actual | 2.012B |
Last 4 Quarters for VONOVIA SE
Below you can see how VNNVF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Dec 31, 2024 |
| Price on release | $30.11 |
| EPS estimate | - |
| EPS actual | -$0.440 |
| Date | Price |
|---|---|
| Dec 25, 2024 | $29.86 |
| Dec 26, 2024 | $30.09 |
| Dec 27, 2024 | $28.50 |
| Dec 30, 2024 | $30.79 |
| Dec 31, 2024 | $30.11 |
| Jan 02, 2025 | $30.10 |
| Jan 03, 2025 | $30.10 |
| Jan 06, 2025 | $30.25 |
| Jan 07, 2025 | $30.25 |
| 4 days before | 0.84% |
| 4 days after | 0.465% |
| On release day | -0.0166% |
| Change in period | 1.31% |
| Release date | May 07, 2025 |
| Price on release | $33.64 |
| EPS estimate | $0.519 |
| EPS actual | $0.658 |
| EPS surprise | 26.78% |
| Date | Price |
|---|---|
| May 01, 2025 | $32.53 |
| May 02, 2025 | $32.53 |
| May 05, 2025 | $32.05 |
| May 06, 2025 | $32.05 |
| May 07, 2025 | $33.64 |
| May 08, 2025 | $33.64 |
| May 09, 2025 | $30.26 |
| May 12, 2025 | $32.63 |
| May 13, 2025 | $32.63 |
| 4 days before | 3.41% |
| 4 days after | -3.00% |
| On release day | 0% |
| Change in period | 0.307% |
| Release date | Aug 06, 2025 |
| Price on release | $30.50 |
| EPS estimate | $0.476 |
| EPS actual | $0.447 |
| EPS surprise | -6.03% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $30.50 |
| Aug 01, 2025 | $31.00 |
| Aug 04, 2025 | $30.50 |
| Aug 05, 2025 | $30.50 |
| Aug 06, 2025 | $30.50 |
| Aug 07, 2025 | $30.50 |
| Aug 08, 2025 | $30.50 |
| Aug 11, 2025 | $33.15 |
| Aug 12, 2025 | $32.94 |
| 4 days before | 0% |
| 4 days after | 8.00% |
| On release day | 0% |
| Change in period | 8.00% |
| Release date | Nov 05, 2025 |
| Price on release | $29.53 |
| EPS estimate | $0.563 |
| EPS actual | $3.20 |
| EPS surprise | 468.38% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $32.19 |
| Oct 31, 2025 | $32.19 |
| Nov 03, 2025 | $29.53 |
| Nov 04, 2025 | $29.53 |
| Nov 05, 2025 | $29.53 |
| Nov 06, 2025 | $29.53 |
| Nov 07, 2025 | $29.53 |
| Nov 10, 2025 | $27.60 |
| Nov 11, 2025 | $27.60 |
| 4 days before | -8.26% |
| 4 days after | -6.54% |
| On release day | 0% |
| Change in period | -14.26% |
VONOVIA SE Earnings Call Transcript Summary of Q3 2025
Vonovia reported 9M 2025 results and remains on track to the upper end of full-year guidance: total EBITDA +6.4% and EBT +6.8%. Management reiterated confidence in continued earnings and organic value growth driven by (a) accelerating organic rent growth (management expects ~5% by 2028, potentially above 5%), (b) a scale/efficiency advantage that generates substantial EBITDA uplift versus peers, and (c) a ramped-up investment program (targeting ~EUR 2bn p.a. by 2028) that is expected to further drive investment-led rent growth. Non-rental EBITDA is being re-accelerated (value-add, craftsman and energy businesses), and recurring sales and development-to-sell are contributing to cash generation. Debt metrics are being actively managed with focus on rating-relevant KPIs (notably ICR); management targets to keep metrics in line with a BBB+ rating and assumes mid-term refinancing rates around ~4% in planning. The CEO transition was announced (Rolf Buch stepping down; Luka joining and becoming CEO in January). Management also highlighted a normalization in the transaction market (increasing activity of smaller deals) and one-off accounting impacts (deferred tax remeasurement due to a future corporate tax change).
